Bayer is pressing ahead with a phase 3 trial of its oral Factor XIa inhibitor asundexian, a new anticoagulant, despite missing efficacy targets in two mid-stage studies. The OCEANIC trial ...

Two children in Nova Scotia are missing. Why wasn't an Amber Alert sent out? The search for two children missing in Pictou County entered a fourth day Monday. Halifax Water is seeking approval of its ...